According to the latest disclosures from the Hong Kong Stock Exchange, on August 27, executive director Wang Yuxiao sold 13,500 shares of Remegen (09995) at an average price of HK$81.5352 per share, for a total transaction value of approximately HK$1.1007 million.
Following the reduction, Wang Yuxiao's latest shareholding stands at 22.2786 million shares, representing a stake of 10.68% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.